Clinical Trial Update: Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients

View source ↗

Summary

A completed clinical trial evaluating whether LDL-apheresis affects plasma PTX3 levels in patients with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Universita di Verona | Conditions: Hypercholesterolemia | Status: COMPLETED